> top > docs > PMC:7386875 > spans > 1296-2271 > annotations

PMC:7386875 / 1296-2271 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T8 25-31 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T9 391-398 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T22 45-61 Disease denotes thrombocytopenia http://purl.obolibrary.org/obo/MONDO_0002049
T23 100-108 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T24 196-204 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T25 228-238 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T26 349-357 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T27 369-379 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T28 628-636 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T11 25-31 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T2 290-295 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T3 391-398 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T4 405-415 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T5 430-435 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T6 437-447 Chemical denotes nafamostat http://purl.obolibrary.org/obo/CHEBI_135466
T7 453-465 Chemical denotes dipyridamole http://purl.obolibrary.org/obo/CHEBI_4653
T8 527-536 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T9 781-786 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T6 45-61 Phenotype denotes thrombocytopenia http://purl.obolibrary.org/obo/HP_0001873

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T9 110-266 Sentence denotes Given thrombotic complications are central determinants of the high mortality rate in COVID-19, strategies to prevent thrombosis are of critical importance.
T10 267-545 Sentence denotes Several antithrombotic drugs have been proposed as potential therapies to prevent COVID-19-associated thrombosis, including heparin, FXII inhibitors, fibrinolytic drugs, nafamostat, and dipyridamole, many of which also possess pleiotropic anti-inflammatory or antiviral effects.
T11 546-852 Sentence denotes The growing awareness and mechanistic understanding of the prothrombotic state of COVID-19 patients are driving efforts to more stringent diagnostic screening for thrombotic complications and to the early institution of antithrombotic drugs, for both the prevention and therapy of thrombotic complications.

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
55 637-645 Species denotes patients Tax:9606
57 391-398 Chemical denotes heparin MESH:D006493
58 437-447 Chemical denotes nafamostat MESH:C032855
59 453-465 Chemical denotes dipyridamole MESH:D004176
79 45-61 Disease denotes thrombocytopenia MESH:D013921
80 100-108 Disease denotes COVID-19 MESH:C000657245
81 116-140 Disease denotes thrombotic complications MESH:D013927
82 178-187 Disease denotes mortality MESH:D003643
83 196-204 Disease denotes COVID-19 MESH:C000657245
84 228-238 Disease denotes thrombosis MESH:D013927
85 349-357 Disease denotes COVID-19 MESH:C000657245
86 369-379 Disease denotes thrombosis MESH:D013927
87 628-636 Disease denotes COVID-19 MESH:C000657245
88 709-733 Disease denotes thrombotic complications MESH:D013927
89 827-851 Disease denotes thrombotic complications MESH:D013927